CRISPR Medicine News, 23 December 2020 | Gene-Editing IND and Pre-Clinical Update

Call for Papers:

Frontiers in Genome Editing

Open for submissions:

Abstract Deadline: 2^nd January 2021

Final Manuscript Deadline: 2^nd May 2021

Allogene Therapeutics off-the-shelf CAR-T cancer therapies

This week’s gene-editing update looks at an investigational new drug (IND) programme and a pre-clinical programme for gene-edited CAR T-cell therapies for renal cell carcinoma, haematological cancers, and multiple myeloma.

Career CRISPR Medicine

Freelancer | CRISPR Medicine News - Anyplace

MERRY CHRISTMAS from all of us

Dear readers

Thank you so much for your support this year.

We look forward to bringing you lots of new and exciting treats to read next year.

We wish you a very merry Christmas, a wonderful holiday with friends and family and a very joyous New Year.

Happy Reading!

- All of us at CRISPR Medicine News

p.s. if you have questions or suggestions, you can reach out to us directly at editor@crisprmedicinenews.com. We love hearing from readers! And you can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up for our newsletter yourself here.

CRISPR QC pioneers streamlined and automated CRISPR quality control tools to accelerate research while improving accuracy and performance.

Welcome to CRISPR Cuts, Synthego’s official podcast dedicated to the world of genome engineering. We are in an age of CRISPR revolution! This cutting-edge genome editing technology is quickly becoming a part of our daily conversation and lives, impacting our healthcare, the food we eat, and the materials we use.